이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Medpace Holdings 관리
관리 기준 확인 4/4
Medpace Holdings' CEO는 August Troendle, Jul1992 에 임명되었습니다 의 임기는 31.92 년입니다. 총 연간 보상은 $ 1.65M, 49.5% 로 구성됩니다. 49.5% 급여 및 50.5% 보너스(회사 주식 및 옵션 포함). 는 $ 2.17B 가치에 해당하는 회사 주식의 17.43% 직접 소유합니다. 2.17B. 경영진과 이사회의 평균 재임 기간은 각각 5.3 년과 5.8 년입니다.
주요 정보
August Troendle
최고 경영자
US$1.6m
총 보상
| CEO 급여 비율 | 49.5% |
| CEO 임기 | 31.9yrs |
| CEO 소유권 | 17.4% |
| 경영진 평균 재임 기간 | 5.3yrs |
| 이사회 평균 재임 기간 | 5.8yrs |
최근 관리 업데이트
Recent updates
What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18
Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Oct 10Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 26Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Aug 28We Think Medpace Holdings (NASDAQ:MEDP) Can Manage Its Debt With Ease
Aug 01Medpace 2022 revenue guidance above consensus estimate as Q2 beats on top, bottom lines
Jul 25CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$312m |
| Dec 31 2023 | US$2m | US$814k | US$283m |
| Sep 30 2023 | n/a | n/a | US$273m |
| Jun 30 2023 | n/a | n/a | US$268m |
| Mar 31 2023 | n/a | n/a | US$257m |
| Dec 31 2022 | US$2m | US$770k | US$245m |
| Sep 30 2022 | n/a | n/a | US$227m |
| Jun 30 2022 | n/a | n/a | US$209m |
| Mar 31 2022 | n/a | n/a | US$199m |
| Dec 31 2021 | US$6m | US$697k | US$181m |
| Sep 30 2021 | n/a | n/a | US$182m |
| Jun 30 2021 | n/a | n/a | US$175m |
| Mar 31 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$4m | US$608k | US$145m |
| Sep 30 2020 | n/a | n/a | US$124m |
| Jun 30 2020 | n/a | n/a | US$107m |
| Mar 31 2020 | n/a | n/a | US$110m |
| Dec 31 2019 | US$8m | US$504k | US$100m |
| Sep 30 2019 | n/a | n/a | US$93m |
| Jun 30 2019 | n/a | n/a | US$88m |
| Mar 31 2019 | n/a | n/a | US$78m |
| Dec 31 2018 | US$528k | US$420k | US$73m |
| Sep 30 2018 | n/a | n/a | US$61m |
| Jun 30 2018 | n/a | n/a | US$52m |
| Mar 31 2018 | n/a | n/a | US$45m |
| Dec 31 2017 | US$598k | US$419k | US$39m |
보상 대 시장: August 의 총 보상 ($USD 1.65M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 13.50M ).
보상과 수익: August 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
August Troendle (68 yo)
31.9yrs
테뉴어
US$1,646,031
보상
Dr. August James Troendle, M.D. serves as Chairman of CinRx Pharma, LLC. He has been the Chairman, Chief Executive Officer at Medpace Holdings, Inc. since July 1992 and served as its President since July 1...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 31.9yrs | US$1.65m | 17.43% $ 2.3b | |
| President | 2.8yrs | US$945.08k | 0.070% $ 9.1m | |
| CFO & Treasurer | 5.3yrs | US$690.48k | 0.019% $ 2.5m | |
| Executive Vice President of Operations | 7.4yrs | US$1.12m | 0.024% $ 3.2m | |
| Chief Compliance Officer | 12yrs | US$914.64k | 0.043% $ 5.7m | |
| Chief Information Officer | 3.4yrs | 데이터 없음 | 데이터 없음 | |
| Associate Director of Investors Relations | no data | 데이터 없음 | 데이터 없음 | |
| Vice President of Business Development & Marketing | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | no data | 데이터 없음 | 데이터 없음 | |
| Chief Medical Officer of Medical Department | 1.4yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Clinical Monitoring | no data | 데이터 없음 | 데이터 없음 |
5.3yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 관리: MEDP 의 관리팀은 노련하고 경험 (평균 재직 기간 5.3 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & CEO | 31.9yrs | US$1.65m | 17.43% $ 2.3b | |
| Lead Independent Director | 5.8yrs | US$264.98k | 0.0065% $ 848.7k | |
| Independent Director | 5.8yrs | US$217.48k | 0.017% $ 2.2m | |
| Independent Director | 7.9yrs | US$227.35k | 0.0014% $ 190.2k | |
| Independent Director | 7.9yrs | US$234.97k | 0.070% $ 9.2m | |
| Independent Director | 1.4yrs | US$258.37k | 0% $ 0 | |
| Independent Director | 5.1yrs | US$209.98k | 0.00081% $ 106.3k |
5.8yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: MEDP 의 이사회는 경험(평균 재직 기간 5.8 년)으로 간주됩니다.